Federal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine, saying they are reviewing reports of six U.S. cases of a rare and severe type of blood clot in people after receiving the vaccine.
All six cases occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a statement issued by the Food and Drug Administration and the Centers for Disease Control and Prevention.
I’m going to refrain from amateur epidemiology and virology. I’ll just note that, in the Rochester area, there’s a surplus of Moderna and Pfizer appointments at the time. So the notion that this will delay vaccinations, at least here, doesn’t seem to have much validity.